跳至主要内容
临床试验/CTRI/2023/08/056529
CTRI/2023/08/056529招募中3 期

A randomized open labelled comparative clinical study to evaluate the efficacy of Musta Sadhita Takra Basti and Takra Basti in Grahani vis-à-vis Irritable Bowel Syndrome. - NI

Dr Ishwarakeerthi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ? Subjects between the age group of 21 – 65 years irrespective of gender, religion, occupation and socioeconomic status.
  • ? Subjects fit for Basti.
  • ? Subjects fulfilling the Rome IV diagnostic criteria for IBS.
  • ? Subjects who are willing to give a written consent for the treatment

排除标准

  • ? Subjects below 21 years and above 65 years of age.
  • ? Subjects unfit for Basti.
  • ? Condition associated with inflammatory bowel disease, and other systemic illnesses that interfere with the treatment protocol.
  • ? Pregnant and lactating women.

研究者

发起方
Dr Ishwarakeerthi

相似试验